284 Appendices REFERENCES 1. IKNL. Incidence of Lung Cancer in the Netherlands. https://iknl.nl/kankersoorten/ longkanker/registratie/incidentie. 2. Hendriks LEL, Dingemans AMC, De Ruysscher DKM, et al. Lung Cancer in the Netherlands. J Thorac Oncol. 2021;16(3):355-365. doi:10.1016/j.jtho.2020.10.012 3. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40(2):90-97. doi:10.1053/j.ro.2005.01.001 4. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors. J Thorac Oncol. 2015;10(9):1243-1260. doi:10.1097/ JTO.0000000000000630 5. Wang B-Y, Huang J-Y, Chen H-C, et al. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol. 2020;146(1):4352. doi:10.1007/s00432-019-03079-8 6. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new international association for the study of lung cancer/American thoracic society/ European respiratory society international multidisciplinary lung adeno. J Thorac Oncol. 2011;6(9):1496-1504. doi:10.1097/JTO.0b013e318221f701 7. Murakami S, Ito H, Tsubokawa N, et al. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma. Lung Cancer. 2015;90(2):199-204. doi:10.1016/j.lungcan.2015.06.022 8. Yang F, Dong Z, Shen Y, et al. Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern. Lung Cancer. 2020;147(May):187-192. doi:10.1016/j.lungcan.2020.07.021 9. Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med. 1960;10:329-358. 10. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75(12):2844-2852. doi:10.1002/10970142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-# 11. Silver SA, Askin FB. True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol. 1997;21(1):43-51. doi:10.1097/00000478-199701000-00005 12. Travis W, Colby T V. Histological Typing of Lung and Pleural Tumors. 3rd ed. Springer; 1999. 13. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244285. doi:10.1097/JTO.0b013e318206a221 14. Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol. 2012;25(12):1574-1583. doi:10.1038/modpathol.2012.106 15. Mountain C. Revisions in the International System for Staging Lung Cancer. Chest. 1997;110:1710-1717. doi:10.1378/chest.111.6.1710 16. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer. J Thorac Oncol. 2016;11(1):39-51. doi:10.1016/j. jtho.2015.09.009 17. Nicholson AG, Tsao MS, Travis WD, et al. Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. Arch Pathol Lab Med. 2018;142(5):645-661. doi:10.5858/arpa.2017-0245-RA
RkJQdWJsaXNoZXIy MTk4NDMw